A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Study B1621018 will assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
of Two Dose Levels of Pf-04937319 in Japanese Subjects with Type 2 Diabetes Mellitus As
Monotherapy